Similar articles

• HIV or zidovudine myopathy?

  Gherardi R, Chariot P. Gherardi R, et al. Neurology. 1994 Feb;44(2):361-2; author reply 362-4. doi: 10.1212/wnl.44.2.361-b. Neurology. 1994. PMID: 8309597 No abstract available.
• Zidovudine-related myopathy.

  Daniels DG, McCormack SM, McLean KA, Davies PT, Lane RJ. Daniels DG, et al. Lancet. 1990 Nov 17;336(8725):1256. doi: 10.1016/0140-6736(90)92875-i. Lancet. 1990. PMID: 1978099 No abstract available.
• HIV or zidovudine myopathy?

  Dalakas M. Dalakas M. Neurology. 1994 Feb;44(2):360-1; author reply 362-4. doi: 10.1212/wnl.44.2.360-b. Neurology. 1994. PMID: 8309594 No abstract available.
• [Muscular involvement in human immunodeficiency virus infection].

  Laraki R, Lebas J, Baudrimont M, Cabane J, Giral P, Wattiaux MJ, Picard O, Imbert JC. Laraki R, et al. Ann Med Interne (Paris). 1990;141(2):187-92. Ann Med Interne (Paris). 1990. PMID: 2191617 Review. French. No abstract available.
• Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?

  Till M, MacDonell KB. Till M, et al. Ann Intern Med. 1990 Oct 1;113(7):492-4. doi: 10.7326/0003-4819-113-7-492. Ann Intern Med. 1990. PMID: 1975486 Review. No abstract available.